Other peptides under investigation Several additional peptides are being studied for disc-related applications, though with less established evidence: Vasoactive Intestinal Peptide (VIP) has demonstrated the ability to slow disc degeneration progression and improve aggrecan levels in mouse studies
Dibyendu Talukdar, Raja Peary Mohan College (Affiliated to University of Calcutta), India Copyright 2015 Pandey, Singh, Achary and Reddy
NEWS Update 20 January 2025 2024 FDA approvals Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription 27,99 / 30 days cancel any time Subscribe to this journal Receive 12 print issues and online access 269,00 per year only 22,42 per issue Rent or buy this article Prices vary by article type from$1.95 to$39.95 Prices may be subject to local taxes which are calculated during checkout Nature Reviews Drug Discovery 24 , 75-82 (2025) doi: Updates & Corrections Update 20 January 2025 : Information on the financial performance of the new drugs approved and the characteristics of the reviews by the FDA has been added to the article, with an additional column in Table 1 and addition of Figure 4.
Wolverine Blend BPC-157 (10mg) / TB500 (10mg) Description A single-component research material supplied for controlled research environments
Make sure to follow the dosage instructions on the label, or use those in the studies mentioned above
Nothing else comes close
